The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine
Open accessAbstract
Nonlamellar lyotropic liquid crystalline (LLC) lipid nanomaterials have emerged as a promising class of advanced materials for the next generation of nanomedicine, comprising mainly of amphiphilic lipids and functional additives self-assembling into two- and three-dimensional, inverse hexagonal, and cubic nanostructures. In particular, the lyotropic liquid crystalline lipid nanoparticles (LCNPs) have received great interest as nanocarriers for a variety of hydrophobic and hydrophilic small molecule drugs, peptides, proteins, siRNAs, DNAs, and imaging agents. Within this space, there has been a tremendous amount of effort over the last two decades elucidating the self-assembly behavior and structure-function relationship of natural and synthetic lipid-based drug delivery vehicles in vitro, yet successful clinical translation remains sparse due to the lack of understanding of these materials in biological bodies. This review provides an overview of (1) the benefits and advantages of using LCNPs as drug delivery nanocarriers, (2) design principles for making LCNPs with desirable functionalities for drug delivery applications, (3) current understanding of the LLC material-biology interface illustrated by more than 50 in vivo, preclinical studies, and (4) current patenting and translation activities in a pharmaceutical context. Together with our perspectives and expert opinions, we anticipate that this review will guide future studies in developing LCNP-based drug delivery nanocarriers with the objective of translating them into a key player among nanoparticle platforms comprising the next generation of nanomedicine for disease therapy and diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers
Israelachvili, J. N., Mitchell, D. J., & Ninham, B. W. (1976) · Journal of the Chemical Society, Faraday Transactions 2 · doi:10.1039/f29767201525 · Cited by 5,205
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Mechanisms of gene silencing by double-stranded RNA
Meister, G., & Tuschl, T. (2004) · Nature · doi:10.1038/nature02873 · Cited by 2,539
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
Katz, E., & Willner, I. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200400651 · Cited by 2,450
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
The emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,436
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Theranostics: Combining Imaging and Therapy
Kelkar, S. S., & Reineke, T. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200151q · Cited by 1,385
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Structure of the inverted hexagonal (HII) phase, and non-lamellar phase transitions of lipids
Seddon, J. M. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90002-t · Cited by 1,089
Advanced materials and processing for drug delivery: The past and the future
Zhang, Y., Chan, H. F., & Leong, K. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.003 · Cited by 1,000
Lipid-like materials for low-dose, in vivo gene silencing
Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 890
Motornov, M., Roiter, Y., Tokarev, I., & Minko, S. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.10.004 · Cited by 773
Clinical Translation of Nanomedicine
Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 772
The phase diagram of the monoolein/water system: metastability and equilibrium aspects
Qiu, H., & Caffrey, M. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00126-x · Cited by 640
Han, L., & Che, S. (2018) · Advanced Materials · doi:10.1002/adma.201705708 · Cited by 624
Smart hybrid materials by conjugation of responsive polymers to biomacromolecules
Cobo, I., Li, M., Sumerlin, B. S., & Perrier, S. (2015) · Nature Materials · doi:10.1038/nmat4106 · Cited by 574
Cubic lipid-water phases: structures and biomembrane aspects
Larsson, K. (1989) · The Journal of Physical Chemistry · doi:10.1021/j100358a010 · Cited by 561
Surfactant self-assembly objects as novel drug delivery vehicles
Drummond, C. J., & Fong, C. (1999) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(00)00020-0 · Cited by 515
Self-citationOral delivery of anticancer drugs: Challenges and opportunities
Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.020 · Cited by 499
Oral lipid-based drug delivery systems – an overview
Kalepu, S., Manthina, M., & Padavala, V. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.10.001 · Cited by 494
Lyotropic liquid crystal systems in drug delivery
Guo, C., Wang, J., Cao, F., Lee, R. J., & Zhai, G. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.09.006 · Cited by 453
Novel Process for Producing Cubic Liquid Crystalline Nanoparticles (Cubosomes)
Spicer, P. T., Hayden, K. L., Lynch, M. L., Ofori-Boateng, A., & Burns, J. L. (2001) · Langmuir · doi:10.1021/la010161w · Cited by 429
Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., & Park, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1093 · Cited by 382
Current methods for attaching targeting ligands to liposomes and nanoparticles
Nobs, L., Buchegger, F., Gurny, R., & Allémann, E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20098 · Cited by 379
Characterization and potential applications of nanostructured aqueous dispersions
Yaghmur, A., & Glatter, O. (2009) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2008.07.007 · Cited by 373
Liposomal paclitaxel formulations
Koudelka, Š., & Turánek, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.006 · Cited by 366
Fong, C., Le, T., & Drummond, C. J. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15148g · Cited by 338
Self-citationAngelova, A., Angelov, B., Mutafchieva, R., Lesieur, S., & Couvreur, P. (2011) · Accounts of Chemical Research · doi:10.1021/ar100120v · Cited by 337
pH-Responsive Lyotropic Liquid Crystals for Controlled Drug Delivery
Negrini, R., & Mezzenga, R. (2011) · Langmuir · doi:10.1021/la200591u · Cited by 336
Boyd, B. J., Whittaker, D. V., Khoo, S.-M., & Davey, G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.033 · Cited by 333
Nanotechnology-Based Cosmeceuticals
Lohani, A., Verma, A., Joshi, H., Yadav, N., & Karki, N. (2014) · ISRN Dermatology · doi:10.1155/2014/843687 · Cited by 326
Mulet, X., Boyd, B. J., & Drummond, C. J. (2013) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2012.10.014 · Cited by 315
Self-citationSelf-Assembled Lipid Superstructures: Beyond Vesicles and Liposomes
Barauskas, J., Johnsson, M., & Tiberg, F. (2005) · Nano Letters · doi:10.1021/nl050678i · Cited by 312
Cubic Phase Nanoparticles (Cubosome): Principles for Controlling Size, Structure, and Stability
Barauskas, J., Johnsson, M., Joabsson, F., & Tiberg, F. (2005) · Langmuir · doi:10.1021/la047590p · Cited by 302
Cubosome Dispersions as Delivery Systems for Percutaneous Administration of Indomethacin
Esposito, E., Cortesi, R., Drechsler, M., Paccamiccio, L., Mariani, P., Contado, C., Stellin, E., Menegatti, E., Bonina, F., & Puglia, C. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8176-x · Cited by 259
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
Kompella, U. B., Amrite, A. C., Pacha Ravi, R., & Durazo, S. A. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.04.001 · Cited by 258
Use of machine learning approaches for novel drug discovery
Lima, A. N., Philot, E. A., Trossini, G. H. G., Scott, L. P. B., Maltarollo, V. G., & Honorio, K. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1146250 · Cited by 254
Characterisation of drug release from cubosomes using the pressure ultrafiltration method
Boyd, B. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00262-x · Cited by 245
Rational Design of Multi-Stimuli-Responsive Nanoparticles for Precise Cancer Therapy
An, X., Zhu, A., Luo, H., Ke, H., Chen, H., & Zhao, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b01296 · Cited by 239
Cubic membranes: a legend beyond the Flatland* of cell membrane organization
Almsherqi, Z. A., Kohlwein, S. D., & Deng, Y. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200603055 · Cited by 238
Self-Assembled Structures and p Ka Value of Oleic Acid in Systems of Biological Relevance
Salentinig, S., Sagalowicz, L., & Glatter, O. (2010) · Langmuir · doi:10.1021/la101012a · Cited by 228
In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting
Nasr, M., Ghorab, M. K., & Abdelazem, A. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.12.001 · Cited by 223
A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery
Lu, J. J., Langer, R., & Chen, J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900023v · Cited by 219
Ishida, T., Kirchmeier, M. J., Moase, E. H., Zalipsky, S., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00409-6 · Cited by 216
van ‘t Hag, L., Gras, S. L., Conn, C. E., & Drummond, C. J. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00663a · Cited by 205
Self-citationGan, L., Han, S., Shen, J., Zhu, J., Zhu, C., Zhang, X., & Gan, Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.015 · Cited by 196
Cubic and Hexagonal Liquid Crystals as Drug Delivery Systems
Chen, Y., Ma, P., & Gui, S. (2014) · BioMed Research International · doi:10.1155/2014/815981 · Cited by 196
Leal, C., Bouxsein, N. F., Ewert, K. K., & Safinya, C. R. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1059763 · Cited by 195
Zabara, A., & Mezzenga, R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.052 · Cited by 194
Lopes, L. B., Ferreira, D. A., de Paula, D., Garcia, M. T. J., Thomazini, J. A., Fantini, M. C. A., & Bentley, M. V. L. B. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0143-7 · Cited by 194
Morsi, N. M., Abdelbary, G. A., & Ahmed, M. A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.04.018 · Cited by 192
A critical review of lipid-based nanoparticles for taxane delivery
Feng, L., & Mumper, R. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.07.006 · Cited by 191
Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery
Alabi, C. A., Love, K. T., Sahay, G., Yin, H., Luly, K. M., Langer, R., & Anderson, D. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306529110 · Cited by 188
Han, S., Shen, J.-Q., Gan, Y., Geng, H.-M., Zhang, X.-X., Zhu, C.-L., & Gan, L. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.98 · Cited by 177
Elnaggar, Y., Etman, S., Abdelmonsif, D., & Abdallah, O. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87336 · Cited by 170
BOYD, B., KHOO, S., WHITTAKER, D., DAVEY, G., & PORTER, C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.020 · Cited by 169
Self-assembled “nanocubicle” as a carrier for peroral insulin delivery
Chung, H., Kim, J., Um, J. Y., Kwon, I. C., & Jeong, S. Y. (2002) · Diabetologia · doi:10.1007/s00125-001-0751-z · Cited by 166
Oil-Loaded Monolinolein-Based Particles with Confined Inverse Discontinuous Cubic Structure (Fd 3 m)
Yaghmur, A., de Campo, L., Salentinig, S., Sagalowicz, L., Leser, M. E., & Glatter, O. (2006) · Langmuir · doi:10.1021/la052109w · Cited by 164
Direct visualization of dispersed lipid bicontinuous cubic phases by cryo-electron tomography
Demurtas, D., Guichard, P., Martiel, I., Mezzenga, R., Hébert, C., & Sagalowicz, L. (2015) · Nature Communications · doi:10.1038/ncomms9915 · Cited by 162
Cuboplexes: Topologically Active siRNA Delivery
Kim, H., & Leal, C. (2015) · ACS Nano · doi:10.1021/acsnano.5b03902 · Cited by 158
Lopes, L. B., Lopes, J. L. C., de Oliveira, D. C. R., Thomazini, J. A., Garcia, M. T. J., Fantini, M. C. D. A., Collett, J. H., & Bentley, M. V. L. B. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.02.003 · Cited by 156
Angelov, B., Angelova, A., Filippov, S. K., Drechsler, M., Štěpánek, P., & Lesieur, S. (2014) · ACS Nano · doi:10.1021/nn5012946 · Cited by 151
Responsive self-assembled nanostructured lipid systems for drug delivery and diagnostics
Fong, W., Negrini, R., Vallooran, J. J., Mezzenga, R., & Boyd, B. J. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.08.077 · Cited by 149
Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes
Barauskas, J., Cervin, C., Jankunec, M., Špandyreva, M., Ribokaitė, K., Tiberg, F., & Johnsson, M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.016 · Cited by 145
Zhai, J., Luwor, R. B., Ahmed, N., Escalona, R. M., Tan, F. H., Fong, C., Ratcliffe, J., Scoble, J. A., Drummond, C. J., & Tran, N. L. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b08125 · Cited by 142
Self-citationPEGylated nanomedicines: recent progress and remaining concerns
Vllasaliu, D., Fowler, R., & Stolnik, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.866651 · Cited by 137
Nanocarrier Fabrication and Macromolecule Drug delivery: Challenges and Opportunities
Agrahari, V., Agrahari, V., & Mitra, A. K. (2016) · Therapeutic Delivery · doi:10.4155/tde-2015-0012 · Cited by 137
Bicontinuous cubic phase nanoparticle lipid chemistry affects toxicity in cultured cells
Hinton, T. M., Grusche, F., Acharya, D. P., Shukla, R., Bansal, V., Waddington, L. J., Monaghan, P., & Muir, B. W. (2013) · Toxicology Research · doi:10.1039/c3tx50075f · Cited by 135
Couvreur, P., Reddy, L. H., Mangenot, S., Poupaert, J. H., Desmaële, D., Lepêtre‐Mouelhi, S., Pili, B., Bourgaux, C., Amenitsch, H. W., & Ollivon, M. (2008) · Small · doi:10.1002/smll.200700731 · Cited by 131
Sosinsky, G. E., Crum, J. K., Jones, Y., Lanman, J. K., Smarr, B. L., Terada, M., Martone, M. E., Deerinck, T. J., Johnson, J. E., & Ellisman, M. H. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2007.09.002 · Cited by 131
Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy
Jain, V. K., Swarnakar, N. K., Mishra, P. R., Verma, A., Kaul, A., Mishra, A. K., & Jain, N. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.056 · Cited by 129
Wu, H., Li, J., Zhang, Q., Yan, X., Guo, L., Gao, X., Qiu, M., Jiang, X., Lai, R., & Chen, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.012 · Cited by 129
An active role for machine learning in drug development
Murphy, R. F. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.576 · Cited by 126
Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study
Esposito, E., Mariani, P., Ravani, L., Contado, C., Volta, M., Bido, S., Drechsler, M., Mazzoni, S., Menegatti, E., Morari, M., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.015 · Cited by 121
Azhari, H. N., Strauss, M., Hook, S. M., Boyd, B. J., & Rizwan, S. B. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.05.001 · Cited by 121
Hao, J., Wang, X., Bi, Y., Teng, Y., Wang, J., Li, F., Li, Q., Zhang, J., Fengguang, G., & Liu, J. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.09.059 · Cited by 120
Conn, C. E., & Drummond, C. J. (2013) · Soft Matter · doi:10.1039/c3sm27743g · Cited by 120
Self-citationChong, J. Y. T., Mulet, X., Waddington, L. J., Boyd, B. J., & Drummond, C. J. (2012) · Langmuir · doi:10.1021/la301874v · Cited by 118
Self-citationAngelov, B., Angelova, A., Drechsler, M., Garamus, V. M., Mutafchieva, R., & Lesieur, S. (2015) · Soft Matter · doi:10.1039/c5sm00169b · Cited by 117
Lipid cubic phases for improved topical drug delivery in photodynamic therapy
Bender, J., Ericson, M. B., Merclin, N., Iani, V., Rosén, A., Engström, S., & Moan, J. E. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.010 · Cited by 115
Drug-Loaded Fluorescent Cubosomes: Versatile Nanoparticles for Potential Theranostic Applications
Murgia, S., Bonacchi, S., Falchi, A. M., Lampis, S., Lippolis, V., Meli, V., Monduzzi, M., Prodi, L., Schmidt, J., Talmon, Y., et al. (2013) · Langmuir · doi:10.1021/la401047a · Cited by 114
pH-responsive lyotropic liquid crystals and their potential therapeutic role in cancer treatment
Negrini, R., Fong, W., Boyd, B. J., & Mezzenga, R. (2015) · Chemical Communications · doi:10.1039/c4cc10274f · Cited by 112
Rizwan, S. B., McBurney, W. T., Young, K., Hanley, T. L., Boyd, B. J., Rades, T., & Hook, S. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.020 · Cited by 112
Zhai, J., Hinton, T. M., Waddington, L. J., Fong, C., Tran, N. L., Mulet, X., Drummond, C. J., & Muir, B. W. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b02797 · Cited by 112
Self-citationNeurotrophin delivery using nanotechnology
Angelova, A., Angelov, B., Drechsler, M., & Lesieur, S. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.010 · Cited by 108
Cancer-Cell-Targeted Theranostic Cubosomes
Caltagirone, C., Falchi, A. M., Lampis, S., Lippolis, V., Meli, V., Monduzzi, M., Prodi, L., Schmidt, J., Sgarzi, M., Talmon, Y., et al. (2014) · Langmuir · doi:10.1021/la501332u · Cited by 108
Luo, Q., Lin, T., Zhang, C. Y., Zhu, T., Wang, L., Ji, Z., Jia, B., Tao, G., Peng, D., & Chen, W. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.036 · Cited by 103
Wu, W. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s8311 · Cited by 97
Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier
Tam, V. H., Sosa, C. L., Liu, R., Yao, N., & Priestley, R. D. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.031 · Cited by 97
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers
Lamberti, M., Zappavigna, S., Sannolo, N., Porto, S., & Caraglia, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.913568 · Cited by 93
Cubic Phases as Delivery Systems for Peptide Drugs
Ericsson, B., Eriksson, P. O., Löfroth, J., & Engström, S. (1991) · ACS symposium series · doi:10.1021/bk-1991-0469.ch022 · Cited by 93
Lynch, M. L., Ofori-Boateng, A., Hippe, A., Kochvar, K. A., & Spicer, P. T. (2003) · Journal of Colloid and Interface Science · doi:10.1016/s0021-9797(02)00016-4 · Cited by 92
Topical non-invasive gene delivery using gemini nanoparticles in interferon-γ-deficient mice
Badea, I., Wettig, S. D., Verrall, R. E., & Földvári, M. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.002 · Cited by 89
Abdelrahman, F. E., Elsayed, I., Gad, M. K., Badr, A., & Mohamed, M. I. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.064 · Cited by 87
Oil and drug control the release rate from lyotropic liquid crystals
Martiel, I., Baumann, N., Vallooran, J. J., Bergfreund, J., Sagalowicz, L., & Mezzenga, R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.034 · Cited by 87
Angelov, B., Angelova, A., Vainio, U., Garamus, V. M., Lesieur, S., Willumeit‐Römer, R., & Couvreur, P. (2009) · Langmuir · doi:10.1021/la804225j · Cited by 87
Bender, J., Simonsson, C., Smedh, M., Engström, S., & Ericson, M. B. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.020 · Cited by 86
Sagnella, S. M., Gong, X., Moghaddam, M. J., Conn, C. E., Kimpton, K., Waddington, L. J., Krodkiewska, I., & Drummond, C. J. (2010) · Nanoscale · doi:10.1039/c0nr00781a · Cited by 84
Self-citationZabara, A., Chong, J. Y. T., Martiel, I., Stark, L., Cromer, B. A., Speziale, C., Drummond, C. J., & Mezzenga, R. (2018) · Nature Communications · doi:10.1038/s41467-018-02996-5 · Cited by 84
Self-citationGershkovich, P., Wasan, E. K., Lin, M., Sivak, O., Leon, C. G., Clement, J. G., & Wasan, K. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp140 · Cited by 83
Barauskas, J., Misiūnas, A., Gunnarsson, T., Tiberg, F., & Johnsson, M. (2006) · Langmuir · doi:10.1021/la060295f · Cited by 82
Zhai, J., Scoble, J. A., Li, N., Lovrecz, G. O., Waddington, L. J., Tran, N. L., Muir, B. W., Coia, G., Kirby, N. M., Drummond, C. J., et al. (2014) · Nanoscale · doi:10.1039/c4nr05200e · Cited by 81
Self-citationAleandri, S., Bandera, D., Mezzenga, R., & Landau, E. M. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b03469 · Cited by 81
Tran, N. L., Bye, N., Moffat, B. A., Wright, D. K., Cuddihy, A. R., Hinton, T. M., Hawley, A. M., Reynolds, N. P., Waddington, L. J., Mulet, X., et al. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.10.028 · Cited by 81
Self-citationJohnsson, M., Barauskas, J., Norlin, A., & Tiberg, F. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.402 · Cited by 80
Sponge Phases and Nanoparticle Dispersions in Aqueous Mixtures of Mono- and Diglycerides
Valldeperas, M., Wisniewska, M. A., Ram-On, M., Kesselman, E., Danino, D., Nylander, T., & Barauskas, J. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b01356 · Cited by 80
Xu, P., Yang, Z., Chen, M., Yang, M., Chen, J., & Fang, W. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54967 · Cited by 79
Li, J., Wu, L., Wu, W., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.07.057 · Cited by 77
Incorporation of antimicrobial peptides in nanostructured lipid membrane mimetic bilayer cubosomes
Meikle, T. G., Zabara, A., Waddington, L. J., Separovic, F., Drummond, C. J., & Conn, C. E. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.01.004 · Cited by 77
Self-citationCubic Phases and Cubic Phase Dispersions in a Phospholipid-Based System
Johnsson, M., Barauskas, J., & Tiberg, F. (2005) · Journal of the American Chemical Society · doi:10.1021/ja043331a · Cited by 76
Mulet, X., Gong, X., Waddington, L. J., & Drummond, C. J. (2009) · ACS Nano · doi:10.1021/nn900671u · Cited by 76
Self-citationRattanapak, T., Birchall, J. C., Young, K., Ishii, M., Meglinski, I. V., Rades, T., & Hook, S. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.018 · Cited by 76
SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications
Nilsson, C., Barrios‐Lopez, B., Kallinen, A., Laurinmäki, P., Butcher, S. J., Raki, M., Weisell, J., Bergström, K., Larsen, S. W., Østergaard, J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.055 · Cited by 75
Glycerol Monooleate-Based Nanocarriers for siRNA Delivery in Vitro
Zhen, G., Hinton, T. M., Muir, B. W., Shi, S., Tizard, M. L., McLean, K. M., Hartley, P. G., & Gunatillake, P. A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200662f · Cited by 73
Yaghmur, A., Sartori, B., & Rappolt, M. (2012) · Langmuir · doi:10.1021/la3019716 · Cited by 72
Approaches to Oral Drug Delivery for Challenging Molecules
Mustata, G. I., & Dinh, S. M. (2006) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v23.i2.20 · Cited by 71
Protein entrapment in PEGylated lipid nanoparticles
Angelova, A., Angelov, B., Drechsler, M., Garamus, V. M., & Lesieur, S. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.006 · Cited by 71
Szlęzak, M., Nieciecka, D., Joniec, A., Pękała, M., Górecka, E., Emo, M., Stébé, M. J., Krysiński, P., & Bilewicz, R. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12889 · Cited by 70
Liquid crystalline phase nanodispersions enable skin delivery of siRNA
Vicentini, F. T. M. C., Depieri, L. V., Polizello, A. C. M., Ciampo, J. O. D., Spadaro, A. C. C., Fantini, M. C. D. A., & Bentley, M. V. L. B. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.08.011 · Cited by 68
Tran, N. L., Hocquet, M., Eon, B., Sangwan, P., Ratcliffe, J., Hinton, T. M., White, J., Ozcelik, B., Reynolds, N. P., & Muir, B. W. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.02.048 · Cited by 68
Self-citationNguyen, T., Hanley, T. L., Porter, C. J. H., Larson, I. C., & Boyd, B. J. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.07.0006 · Cited by 67
Tian, Y., Li, J., Zhu, J., Zhu, N., Zhang, H., Liang, L., & Sun, L. (2017) · Medical Science Monitor · doi:10.12659/msm.904683 · Cited by 67
Interaction of dispersed cubic phases with blood components
Bode, J. C., Kuntsche, J., Funari, S. S., & Bunjes, H. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.016 · Cited by 65
Controlling enzymatic activity and kinetics in swollen mesophases by physical nano-confinement
Sun, W., Vallooran, J. J., Zabara, A., & Mezzenga, R. (2014) · Nanoscale · doi:10.1039/c4nr01394h · Cited by 56
Zhai, J., Suryadinata, R., Luan, B., Tran, N. L., Hinton, T. M., Ratcliffe, J., Hao, X., & Drummond, C. J. (2016) · Faraday Discussions · doi:10.1039/c6fd00039h · Cited by 56
Self-citationPatel, N. V., Thakkar, V. T., Korat, V., Baldaniya, L. H., Gohel, M. C., & Gandhi, T. R. (2016) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.187343 · Cited by 56
Monoolein-based cubosomes affect lipid profile in HeLa cells
Rosa, A., Murgia, S., Putzu, D., Meli, V., & Falchi, A. M. (2015) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2015.08.017 · Cited by 55
Tailoring liquid crystalline lipid nanomaterials for controlled release of macromolecules
Bisset, N. B., Boyd, B. J., & Dong, Y. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.072 · Cited by 54
Ali, M. A., Kataoka, N., Ranneh, A., Iwao, Y., Noguchi, S., Oka, T., & Itai, S. (2016) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c16-00513 · Cited by 53
Dioctadecyldimethylammonium:Monoolein Nanocarriers for Efficient in Vitro Gene Silencing
Oliveira, A. C., Martens, T., Raemdonck, K., Adati, R. D., Feitosa, E., Botelho, C., Gomes, A. C., Braeckmans, K., & Oliveira, M. E. C. D. R. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am500793y · Cited by 50
Cubosome nanoparticles potentiate immune properties of immunostimulants
Wang, D., Luo, L., Zheng, S., Niu, Y., Bo, R., Huang, Y., Xing, J., Li, Z., & Liu, Z. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s110406 · Cited by 47
Water quantitatively induces the mucoadhesion of liquid crystalline phases of glyceryl monooleate
Lee, J., Young, S. A., & Kellaway, I. W. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775956 · Cited by 46
Size and Phase Control of Cubic Lyotropic Liquid Crystal Nanoparticles
Hartnett, T. E., Ladewig, K., O’Connor, A. J., Hartley, P. G., & McLean, K. M. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp502898a · Cited by 45
Lipid Self-Assemblies and Nanostructured Emulsions for Cosmetic Formulations
Kulkarni, C. V. (2016) · Cosmetics · doi:10.3390/cosmetics3040037 · Cited by 41
Why Do Membranes of Some Unhealthy Cells Adopt a Cubic Architecture?
Xiao, Q., Wang, Z., Williams, D., Leowanawat, P., Peterca, M., Sherman, S. E., Zhang, S., Hammer, D. A., Heiney, P. A., King, S. R., et al. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00284 · Cited by 40
Clickable Cubosomes for Antibody-Free Drug Targeting and Imaging Applications
Alcaraz, N., Liu, Q., Hanssen, E. G., Johnston, A. P. R., & Boyd, B. J. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00659 · Cited by 40
Double Click: Dual Functionalized Polymeric Micelles with Antibodies and Peptides
Chan, D. P. Y., Owen, S. C., & Shoichet, M. S. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300511a · Cited by 39
Twofold Light and Magnetic Responsive Behavior in Nanoparticle–Lyotropic Liquid Crystal Systems
Vallooran, J. J., Handschin, S., Bolisetty, S., & Mezzenga, R. (2012) · Langmuir · doi:10.1021/la300449q · Cited by 39
Evolution of cubic membranes as antioxidant defence system
Deng, Y., & Almsherqi, Z. A. (2015) · Interface Focus · doi:10.1098/rsfs.2015.0012 · Cited by 34
Ali, M. A., Noguchi, S., Iwao, Y., Oka, T., & Itai, S. (2016) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c15-00984 · Cited by 33
In vivo hair growth-promoting efficacies of herbal extracts and their cubosomal suspensions
Seo, S. R., Kang, G., Ha, J. W., & Kim, J. (2013) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2012.12.037 · Cited by 32
Le, T. C., & Tran, N. L. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b00075 · Cited by 29
Self-citationPredicting the Complex Phase Behavior of Self-Assembling Drug Delivery Nanoparticles
Le, T. C., Mulet, X., Burden, F. R., & Winkler, D. A. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3006402 · Cited by 27
Tajik‐Ahmadabad, B., Mechler, Á., Muir, B. W., McLean, K. M., Hinton, T. M., Separovic, F., & Polyzos, A. (2017) · ChemBioChem · doi:10.1002/cbic.201600613 · Cited by 26
Lapteva, M., & Kalia, Y. N. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.783008 · Cited by 23
Gong, X., Moghaddam, M. J., Sagnella, S. M., Conn, C. E., Mulet, X., Danon, S. J., Waddington, L. J., & Drummond, C. J. (2011) · Soft Matter · doi:10.1039/c1sm05330b · Cited by 22
Self-citationMelanoma therapy with transdermal mitoxantrone cubic phases
Yu, X., Du, L., Zhu, L., Liu, X., Zhang, B., Gui-ying, F., & Jin, Y. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1024898 · Cited by 21
Sturm, R. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.11.01 · Cited by 18
Speziale, C., Zabara, A., Drummond, C. J., & Mezzenga, R. (2017) · ACS Nano · doi:10.1021/acsnano.7b06838 · Cited by 18
Self-citationMembrane-Mimetic Inverse Bicontinuous Cubic Phase Systems for Encapsulation of Peptides and Proteins
Meikle, T. G., Drummond, C. J., Separovic, F., & Conn, C. E. (2017) · Advances in biomembranes and lipid self-assembly · doi:10.1016/bs.abl.2017.01.002 · Cited by 8
Self-citation
Cited by
Terreni, M., Taccani, M., & Pregnolato, M. (2021) · Molecules · doi:10.3390/molecules26092671 · Cited by 596
Eleraky, N. E., Allam, A., Hassan, S. B., & Omar, M. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020142 · Cited by 342
Advanced Functional Liquid Crystals
Uchida, J., Soberats, B., Gupta, M., & Kato, T. (2022) · Advanced Materials · doi:10.1002/adma.202109063 · Cited by 315
Metadata
- Authors
- Zhai, J., Fong, C., Tran, N., & Drummond, C. J.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-05-13
- Volume
- 13
- Issue
- 6
- Pages
- 6178-6206
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2943987854
- Cited by
- 280
- References
- 162
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.